2m 2m 2m 2m 2m 2m 2m
Amphastar Pharma (AMPH)
NASDAQ
$20.15+$0.21 (+1.05%)
Price as of Aug 03, 2026 8:02 AM EDT- $879.2MMarket Cap
- -5.99%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Amphastar Pharma (AMPH)
$20.15+$0.21 (+1.05%)
AMPH | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $19.94 | ||
Change | -$0.44 (-2.16%) | ||
Open | $20.35 | ||
High | $20.41 | ||
Low | $19.66 | ||
Previous Close | $20.38 | ||
Volume | 367,629 | ||
30-Day Average Volume | 400,035 | ||
1-Week Change | 6.52% | ||
1-Month Change | -1.19% | ||
1-Year Change | -5.99% | ||
3-Year Change | -67.14% | ||
5-Year Change | -4.82% | ||
Fundamentals | |||
Shares Outstanding | 44.1M | ||
Total Assets | $1.6B | ||
Market Cap | $879.2M | ||
Enterprise Value | $1.3B | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | $6.4M | ||
Free Cash Flow | $38.3M | ||
EBIT | $12.3M | ||
EBITDA | $18.5M | ||
Net Working Capital | $469.2M | ||
EPS | $0.14 | ||
Enterprise Value/EBITDA | 71 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | 142 | ||
PEG | -2 | ||
Price/Free Cash Flow | 23 | ||
Price/Operating Cash Flow | 18 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue